✦ LIBER ✦

49 Long acting LHRH analogue versus LHBH plus cyproterone acetate, versus cyproterone acetate alone in treatment of advanced prostate cancer

✍ Scribed by F. Di Silverio; R. Tenaglia; A. Biggio; G. D'Eramo

Book ID: 116005296
Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 117 KB
Volume: 23
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(85)90372-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LHRH agonist ICI 118.630 (Zoladex depot)

LHRH agonist ICI 118.630 (Zoladex depot) (Z) versus Z plus Cyproterone Acetate (CPA) in advanced prostatic cancer. Preliminary report

✍ Dongiovanni, V.; Bertetto, O.; Clerico, M.; Calciati, A. 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 126 KB

Short-term versus long-term addition of

Short-term versus long-term addition of cyproterone acetate to buserelin therapy in comparison with orchidectomy in the treatment of metastatic prostate cancer

✍ J. G. M. Klijn; H. J. De Voogt; U. E. Studer; F. H. Schröder; R. Sylvester; M. D 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB 👁 3 views